Browse Related Topics For:

Generic Drugs

158
Pharmaceutical
120
Patents
101
Prescription Drugs
79
Pharmaceutical Manufacturers
78
FDA
68
Pharmaceutical Patents
65
ANDA
55
SCOTUS
47
FTC
43
Reverse Payment Settlement Agreements
41
FTC v Actavis
41
Patent Litigation
40
Pay-For-Delay
39
Hatch-Waxman
39
Patent Infringement
36
Drug Manufacturers
29
Actavis Inc.
25
Antitrust Litigation
23
Preemption
17
Biosimilars
15
Infringement
15
Labeling
13
Design Defects
13
FDCA
13
Manufacturers
12
Settlement
12
Teva Pharmaceuticals
11
Failure To Warn
10
Appeals
10
Healthcare
10
Mylan Pharmaceuticals
10
Popular
9
AstraZeneca
9
Medical Devices
9
Mutual Pharmaceuticals v Bartlett
9
Watson Pharmaceuticals
8
Antitrust Provisions
8
DOJ
8
EU
8
Warning Labels
7
Biotechnology
7
Class Action
7
Product Hopping
6
Affordable Care Act
6
Antitrust Investigations
6
CA Supreme Court
6
Government Investigations
6
Novartis
6
RanBaxy
6
Reverse Payments
6
Sherman Act
6
Trademarks
5
Cipro
5
Corporate Counsel
5
Jurisdiction
5
Medicaid
5
OIG
5
PLIVA v Mensing
5
Prior Art
5
Sandoz
4
Anti-Competitive
4
Bayer
4
BPCIA
4
China
4
Competition
4
HHS
4
Intellectual Property Litigation
4
Liability
4
Mensing
4
Nexium
4
Obviousness
4
Orphan Drugs
4
Patent Applications
4
Pharmacies
4
Professional Conferences
4
Rule-of-Reason Analysis
4
Wyeth
3
Actavis
3
Apotex
3
Brand
3
Cartwright Act
3
Cephalon
3
CMS
3
DaimlerAG
3
Duty to Deal
3
Eli Lilly
3
European Commission
3
False Claims Act
3
First Sale Doctrine
3
GDUFA
3
Generic
3
GlaxoSmithKline
3
Hoffman LaRoche
3
Life Sciences
3
Medicare
3
Merck
3
Misrepresentation
3
Otsuka Pharmaceutical
3
Patent Trial and Appeal Board
3
Patent-Eligible Subject Matter
3
Pfizer
3
Preliminary Injunctions
3
Subpoenas
2
Abbott Laboratories
2
America Invents Act
2
Anticompetitive Agreements
2
Antitrust Division
2
Biologics Price Competition and Innovation Act of 2009
2
Cartels
2
Claim Construction
2
Clinical Trials
2
Copyright
2
Declaratory Judgments
2
Drug Safety
2
Exports
2
Food Safety
2
Google
2
Health Insurance
2
Healthcare Reform
2
Hospitals
2
Injunctions
2
Innovation
2
Inter Partes Review Proceedings
2
Jazz Pharmaceuticals
2
Johnson & Johnson
2
Licenses
2
Medicare Modernization Act
2
Medicare Part D
2
Monopolization
2
Motion to Dismiss
2
Multinationals
2
Notice Requirements
2
Nursing Homes
2
Octane Fitness v. ICON
2
Par Pharmaceutical
2
Permanent Injunctions
2
Presumption of Validity
2
Proposed Regulation
2
Qui Tam
2
Recordkeeping Requirements
2
Restraint of Trade
2
Safe Harbors
2
Software
2
Strategic Enforcement Plan
2
Summary Judgment
2
Unfair Competition
2
Whistleblowers
1
AbbVie
1
Abuse of Dominance
1
Acquisitions
1
Advanced Premium Tax Credits
1
Advertising
1
Alien Tort Statute
1
Ambiguous
1
Amended Complaints
1
Amended Legislation
1
Amgen
1
Amnesty
1
AMP v Myriad
1
Anti-Kickback Statute
1
Antitrust Conspiracies
1
Approval
1
Asia Pacific
1
Attorney Generals
1
Australia
1
Auto Parts
1
Automotive Industry
1
Aviation Industry
1
Bad Debt
1
Barack Obama
1
Barclays
1
Biogen Idec
1
Biologics
1
Biopharmaceutical
1
Boeing
1
Bolar Defence
1
Books
1
Bowman v Monsanto
1
BPCI
1
Brand Name Drugs
1
Bribery
1
Burden of Proof
1
Burden-Shifting
1
Cadence Pharmaceuticals Inc.
1
Canada
1
Carve Out Provisions
1
CDC
1
Cessna Aircraft Company
1
Charitable PAPs
1
Chevron Deference
1
Citizen Petitions
1
Civil Monetary Penalty
1
Classen Immunotherapies
1
Clear and Convincing Evidence
1
Complex Litigation
1
Compliance
1
Congressional Investigations & Hearings
1
Contraceptive Coverage Mandate
1
Copyright Infringement
1
Corruption
1
Cost-Sharing
1
Covenant Not to Sue
1
Covered Business Method Patents
1
Covered Business Method Proceedings
1
CPSC
1
Criminal Antitrust Litigation
1
Daiichi Sankyo
1
DaimlerChrysler v Bauman
1
Data Breach
1
Data Protection
1
Defect
1
Deficit Reduction
1
Design Patent
1
Dietary Supplements
1
Direct Purchasers
1
Directed Verdicts
1
Dismissals
1
Disparagement
1
Distributors
1
Doctrine of Equivalents
1
DOHA
1
DQSA
1
Draft Guidance
1
Drug Approvals
1
Drug Compounding
1
Drug Distribution
1
Duty to Train
1
Duty to Warn
1
Edith Ramirez
1
EHR
1
Energy Sector
1
Enforcement
1
Entertainment Industry
1
Exceptional Case
1
Exclusivity
1
Expert Testimony
1
Extraterritoriality Rules
1
FAA
1
False Advertising
1
Federal Budget
1
Federal Jurisdiction
1
Federal Trade Commission Act
1
Fines
1
Food Contamination
1
Food Labeling
1
Foreign Manufacturers
1
Form 8-K
1
Forum
1
Forum Non Conveniens
1
Forum Shopping
1
FRAND
1
Fraud and Abuse
1
Fraudulent Procurement
1
Fresenius
1
FTCA
1
Genentech
1
Genetically Engineered Seed
1
Gilead Sciences
1
Grand Juries
1
Hedge Funds
1
Highmark
1
Highmark v. Allcare
1
Honeywell International
1
Hospital Mergers
1
Hotels
1
Human Genes
1
Imports
1
Inc v Weeks
1
India
1
Information Reports
1
Informed Consent
1
Innovator Liability
1
Inspector General
1
Insurers
1
Intent-to-Use
1
Interest Rates
1
International Arbitration
1
International Treaties
1
Inventions
1
IPR
1
Irreparable Harm
1
IRS
1
ITC
1
Japan
1
Jon Leibowitz
1
Jury Awards
1
Jury Verdicts
1
Justiciable Controversy
1
Kickbacks
1
King v Burwell
1
Kirtsaeng v. John Wiley & Sons
1
Laches
1
Lanham Act
1
Lannett Company
1
Legislative Agendas
1
Libor
1
Lipitor
1
Loss Causation
1
Manufacturing Defects
1
Marketing
1
Material Defects
1
MD Hellicopters
1
Media
1
Medical Device Amendments
1
Medical Research
1
Medicare Advantage
1
MedPAC
1
Medtronic
1
Medtronics
1
Mergers
1
Minimum Contacts
1
Mistrial
1
Monsanto
1
Mootness
1
Myriad
1
Naming Conventions
1
Native American Issues
1
New Guidance
1
New Legislation
1
New Regulations
1
NIH
1
Nike
1
Non-Grandfathered Health Plans
1
Noninfringement
1
Nutritional Supplements
1
Omnicare
1
Online Drug Sales
1
Orange Book
1
Par/Paddock
1
Patent Exhaustion
1
Patent Reform
1
Patent Term Adjustment
1
Patent-in-Suit
1
Patentability Search
1
Patient Self-Referral
1
Patients
1
Personal Jurisdiction
1
PharMerica
1
PHRMA
1
Physician Payments
1
Pleading Standards
1
Post-Grant Review
1
Premarket Approval Applications
1
Prilosec
1
Product Labels
1
Proposed Legislation
1
Public Disclosure
1
Public Meetings
1
Public Performance Rights
1
Putative Class Actions
1
Rebates
1
Registration
1
Reversal
1
Risk Assessment
1
Risk Mitigation
1
Robert Bentley
1
Rulemaking Process
1
Safety Precautions
1
Sales Contracts
1
Sandoz v Amgen
1
Schering-Plough
1
Scope of the Patent Test
1
SEC
1
Settlement Agreements
1
SFDA
1
Shell Oil
1
Spectrum v Sandoz
1
Sport
1
Sports
1
Standard of Proof
1
Standard of Review
1
Standing
1
Standing Objections
1
Stem cells
1
Stocks
1
Stop-Selling Rationale
1
Structured Financial Products
1
Subject Matter Jurisdiction
1
Sun Pharmaceuticals
1
Supplementary Protection Certificate
1
Takeda Pharmaceuticals
1
Tax Credits
1
Textbooks
1
The Clayton Act
1
Trade Secrets
1
Trans-Pacific Partnership
1
Transfer of Venue
1
TRIPS Agreement
1
TRO
1
Twombly/Iqbal Pleading Standard
1
UK
1
Unfair Pricing
1
Veterinary Products
1
Walker Process Claims
1
Wireless Devices
1
Women's Preventable Healthcare Mandates
1
WTO
1
Zyprexa